Faculty, Staff and Student Publications
Open-access journal articles from UTHealth GSBS faculty, staff and students.
Submissions from 2025
Association of Serum Endocannabinoid Levels with Pancreatitis and Pancreatitis-Related Pain, Marc T Goodman, Christina Lombardi, Alexa Torrens, et al.
Nivolumab Plus Relatlimab for Patients With Relapsed or Progressed B-Cell Malignancies in RELATIVITY-022, Ajay K Gopal, Philippe Armand, Sattva S Neelapu, et al.
Immune Checkpoint Inhibitors Plus Debulking Surgery for Patients With Metastatic Renal Cell Carcinoma: Clinical Outcomes and Immunological Correlates of a Prospective Pilot Trial, Sangeeta Goswami, Jianjun Gao, Sreyashi Basu, et al.
Selinexor (KPT-330) in Combination with Immune Checkpoint Inhibition in Uveal Melanoma: A Phase 1B Trial, Mohamed A Gouda, Abdulrazzak Zarifa, Yali Yang, et al.
Venetoclax-Based Combination Regimens in Acute Myeloid Leukemia, Hannah Goulart, Hagop Kantarjian, Naveen Pemmaraju, et al.
Robust Automated Method of Spatial Resolution Measurement in Radiotherapy CT Simulation Images, Pavel Govyadinov, Rick R Layman, Tucker Netherton, et al.
Cord Blood-Derived iNK T Cells as a Platform for Allogeneic Car T Cell Therapy, Maison Grefe, Abel Trujillo-Ocampo, Jelita Clinton, et al.
CA-125 as a Biomarker in Renal Medullary Carcinoma: Integrated Molecular Profiling, Functional Characterization, and Prospective Clinical Validation, Sandra L Grimm, Menuka Karki, Kyle A Blum, et al.
A Novel Case of Glial Transdifferentiation in Renal Medullary Carcinoma Brain Metastasis, Maria A Gubbiotti, Ian E McCutcheon, Priya Rao, et al.
Grape-Pi: Graph-Based Neural Networks for Enhanced Protein Identification in Proteomics Pipelines, Chunhui Gu, Seyyed Mahmood Ghasemi, Yining Cai, et al.
Multicancer Early Detection Tests at a Crossroads: Commercial Availability Ahead of Definitive Evidence, Carmen E Guerra, Jennifer Keating Litton, Carolina E Viswanath, et al.
Bispecific Antibodies in Hematologic and Solid Tumors: Current Landscape and Therapeutic Advances, Lorenzo Guidi, Julian Etessami, Carmine Valenza, et al.
Acute BRCAness Induction and AR Pathway Blockage Through CDK12/7/9 Degradation Enhances PARP Inhibitor Sensitivity in Prostate Cancer, Fu Gui, Baishan Jiang, Jie Jiang, et al.
Functional Characterization of QT Interval Associated SCN5A Enhancer Variants Identify Combined Additive Effects, Lavanya Gunamalai, Parul Singh, Brian Berg, et al.
The ZBTB24-CDCA7-HELLS Axis Suppresses the Totipotent 2C-Like Reprogramming by Maintaining Dux Methylation and Repression, Dan Guo, Zeling Du, Youqi Liu, et al.
A Deconvolution Framework That Uses Single-Cell Sequencing Plus a Small Benchmark Data Set for Accurate Analysis of Cell Type Ratios in Complex Tissue Samples, Shuai Guo, Xiaoqian Liu, Xuesen Cheng, et al.
An Integrative Multiparametric Approach Stratifies Putative Distinct Phenotypes of Blast Phase Chronic Myelomonocytic Leukemia, Kristian Gurashi, Yu-Hung Wang, Fabio M R Amaral, et al.
Mathematical Modeling and Association Analysis Decipher the Impact of the Gut Microbiome on Cancer Immunotherapy, Andreas G Hadjigeorgiou, Constantinos Harkos, Aditya K Mishra, et al.
Management of Aromatase Inhibitor-Associated Bone Loss (AIBL) in Women With Hormone-Sensitive Breast Cancer: An Updated Joint Position Statement of the IOF, CABS, ECTS, IEG, ESCEO, IMS, and SIOG, Peyman Hadji, Matty Aapro, Nasser Al-Dagri, et al.
A Pan-Tumor Review of the Role of Poly(adenosine Diphosphate Ribose) Polymerase Inhibitors, Chadi Hage Chehade, Georges Gebrael, Nicolas Sayegh, et al.
A Phase II Trial of Sitravatinib + Nivolumab After Progression on Immune Checkpoint Inhibitor in Patients With Metastatic Clear Cell RCC, Andrew W Hahn, Nabil Adra, Ulka Vaishampayan, et al.
Spontaneous Tumor Regression and Immunotherapy Response Demonstrate Clonal T-Cell Expansion in Merkel Cell Carcinoma, Patrick Hallaert, John W Roman, Mairead Baker, et al.
Dysregulated SASS6 Expression Promotes Increased Ciliogenesis and Cell Invasion Phenotypes, Eleanor Hargreaves, Rebecca Collinson, Andrew D Jenks, et al.
Lymphodepletion, Tumor-Infiltrating Lymphocytes, and High Versus Low Dose IL-2 Followed by Pembrolizumab in Patients With Metastatic Melanoma, Merve Hasanov, Simin Kiany, Marie-Andrée Forget, et al.
Risk and Prognosis of Hepatocellular Carcinoma in Mexican Americans with Type 2 Diabetes Mellitus, Rikita I Hatia, Lu-Yu Hwang, Ruosha Li, et al.